Suppressed impact of nitric oxide on renal arteriolar function in rats with chronic heart failure

American Journal of Physiology - Renal Physiology

Volumn 276, Issue 1 45-1, 1999, Pages

  Ikenaga, Hideki ^a,b   Ishii, Naohito ^a,c   Didion, Sean P ^a,d   Zhang, Kun ^a,e   Cornish, Kurtis G ^a   Patel, Kaushik P ^a   Mayhan, William G ^a   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NASU RED CROSS HOSPITAL   (Japan)

^c KITASATO UNIVERSITY   (Japan)

^d UNIVERSITY OF IOWA   (United States)

^e Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Angiotensin II; Myocardial infarction; Nitric oxide synthase; Renal microvasculature; Superoxide dismutase

Indexed keywords

NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HEART FAILURE; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASOCONSTRICTION;

EID: 0032891468     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.276.1.f79     Document Type: Article

References (41)

1. Abassi, Z., K. Gurbanov, I. Rubinstein, O. S. Better, A. Hoffman, and J. Winaver. Regulation of intrarenal blood flow in experimental heart failure: role of endothelin and nitric oxide. Am. J. Physiol. 274 (Renal Physiol. 43): F766-F774, 1998.
2. Abassi, Z. A., K. Gurbanov, S. E. Mulroney, C. Potlog, T. J. Opgenorth, A. Hoffman, A. Haramati, and J. Winaver. Impaired nitric oxide-mediated renal vasodilation in rats with experimental heart failure: role of angiotensin II. Circulation 96: 3655-3664, 1997.
3. Baggia, S., K. Perkins, and B. Greenberg. Endothelium-dependent relaxation is not uniformly impaired in chronic heart failure. J. Cardiovasc. Pharmacol. 29: 389-396, 1997.
4. Carmines, P. K. Segment-specific effect of chloride channel blockade on rat renal arteriolar contractile responses to angiotensin II. Am. J. Hypertens. 8: 90-94, 1995.
5. Carmines, P. K., and L. G. Navar. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F1015-F1020, 1989.
6. Casellas, D., and L. G. Navar. In vitro perfusion of juxtamedullary nephrons in rats. Am. J. Physiol. 246 (Renal Fluid Electrolyte Physiol. 15): F349-F358, 1984.
7. Didion, S. P., P. K. Carmines, H. Ikenaga, and W. G. Mayhan. Enhanced constrictor responses of skeletal muscle arterioles during chronic myocardial infarction. Am. J. Physiol. 273 (Heart Circ. Physiol. 42): H1502-H1508, 1997.
8. Didion, S. P., and W. G. Mayhan. Effect of chronic myocardial infarction on in vivo reactivity of skeletal muscle arterioles. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H2403-H2408, 1997.
9. Didion, S. P., and W. G. Mayhan. Impaired endothelium-dependent responses of skeletal muscle arterioles during chronic heart failure: role of oxygen radicals (Abstract). FASEB J. 11: A44, 1997.
10. Drexler, H., E. Hablawetz, W. Lu, U. Riede, and A. Christes. Effects of inhibition of nitric oxide formation on regional blood flow in experimental myocardial infarction. Circulation 86: 255-262, 1992.
11. Drexler, H., D. Hayoz, T. Munzel, B. Hornig, H. Just, H. R. Brunner, and R. Zelis. Endothelial function in chronic congestive heart failure. Am. J. Cardiol. 15: 1596-1601, 1992.
12. Elkayam, U., G. Cohen, H. Gogia, A. Mehra, J. V. Johnson, and P. A. N. Chandraratna. Renal vasodilatory effect of endothelial stimulation in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 28: 176-182, 1996.
13. Fletcher, P. J., J. M. Pfeffer, M. A. Pfeffer, and E. Braunwald. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effect on systolic function. Circ. Res. 49: 618-626, 1981.
14. Goldsmith, S. R., G. S. Francis, A. W. Cowley, Jr., T. B. Levine, and J. N. Cohn. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J. Am. Coll. Cardiol. 1: 1385-1390, 1983.
15. Habib, F., D. Dutka, D. Crossman, C. M. Oakley, and J. G. F. Cleland. Enhanced basal nitric oxide production in heart failure: Another failed counter-regulatory vasodilator mechanism. Lancet 344: 371-373, 1994.
16. Ichihara, A., E. W. Inscho, J. D. Imig, and L. G. Navar. Neuronal nitric oxide synthase modulates rat renal microvascular function. Am. J. Physiol. 274 (Renal Physiol. 43): F516-F524, 1998.
17. Ichikawa, I., T. Yoshioka, A. Fogo, and V. Kon. Role of angiotensin II in altered glomerular hemodynamics in congestive heart failure. Kidney Int. 38, Suppl. 30: S123-S126, 1990.
18. Ikenaga, H., R. W. Fallet, and P. K. Carmines. Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANGII in rat kidney. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F365-F373, 1996.
19. Inscho, E. W., K. Ohishi, and L. G. Navar. Effects of ATP on the pre- and postglomerular juxtamedullary microvasculature. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F886-F893, 1992.
20. ω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol. 176: 219-223, 1990.
21. Ito, S., J. Amin, Y. L. Ren, S. Arima, K. Abe, and O. A. Carretero. Heterogeneity of angiotensin action in renal circulation. Kidney Int. 52: S128-S131, 1997.
22. Ito, S., S. Arima, Y. L. Ren, L. A. Juncos, and O. A. Carretero. Endothelium-derived relaxing factors/nitric oxide modulates angiotensin II action on the isolated perfused rabbit afferent but not efferent arteriole. J. Clin. Invest. 91: 2012-2019, 1993.
23. Johns, T. N. P., and B. J. Olson. Experimental myocardial infarction. I. A method of coronary occlusion in small animals. Ann. Surg. 140: 675-682, 1954.
24. Kiuchi, K., N. Sato, R. P. Shannon, D. E. Vatner, K. Morgan, and S. F. Vatner. Depressed β-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure. Circ. Res. 73: 1013-1023, 1993.
25. Kubo, S. H., T. S. Rector, A. J. Bank, L. Raij, M. D. Kraemer, P. Tadros, M. Beardslee, and M. D. Garr. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am. J. Cardiol. 74: 1133-1136, 1994.
26. Kubo, S. H., T. S. Rector, A. J. Bank, R. E. Williams, and S. M. Heifetz. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circ. Res. 84: 1589-1596, 1991.
27. McMurray, J., M. Chopra, I. Abdullah, W. E. Smith, and H. J. Dargie. Evidence of oxidative stress in chronic heart failure in humans. Eur. Heart J. 14: 1493-1498, 1993.
28. Mohri, M., K. Egashira, T. Tagawa, T. Kuga, H. Tagawa, Y. Harasawa, H. Shimokawa, and A. Takeshita. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension 30: 50-56, 1997.
29. Moridani, B. A., and R. L. Kline. Effect of endogenous L-arginine on the measurement of nitric oxide synthase activity in the rat kidney. Can. J. Physiol. Pharmacol. 74: 1210-1214, 1996.
30. Murakami, K., K. Tsuchiya, M. Naruse, K. Naruse, H. Demura, J. Arai, and H. Nihei. Nitric oxide synthase I immunoreactivity in the macula densa of the kidney is angiotensin II dependent. Kidney Int. 52: S208-S210, 1997.
31. Navar, L. G., E. W. Inscho, D. S. A. Majid, J. D. Imig, L. M. Harrison-Bernard, and K. D. Mitchell. Paracrine regulation of the renal microcirculation. Physiol. Rev. 76: 425-536, 1996.
32. Numabe, A., T. Nishikimi, K. Komatsu, and E. D. Frohlich. Intrarenal hemodynamics in low- and high-output cardiac failure in rats. Am. J. Med. Sci. 308: 331-337, 1994.
33. Ohishi, K., P. K. Carmines, E. W. Inscho, and L. G. Navar. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F900-F906, 1992.
34. O'Murchu, B., V. M. Miller, M. A. Perrella, and J. C. Burnett, Jr. Increased production of nitric oxide in coronary arteries during congestive heart failure. J. Clin. Invest. 93: 165-171, 1994.
35. Roman, R. J., P. K. Carmines, R. Loutzenhiser, and J. D. Conger. Direct studies on the control of the renal microcirculation. J. Am. Soc. Nephrol. 2: 136-149, 1991.
36. Schunkert, H., S.-S. Tang, S. E. Litwin, D. Diamant, G. Riegger, V. J. Dzau, and J. R. Ingelfinger. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc. Res. 27: 731-735, 1993.
37. Smith, C. J., D. Sun, C. Hoegler, B. S. Roth, X. Zhang, G. Zhao, X. B. Xu, Y. Kobari, K. Pritchard, Jr., W. C. Sessa, and T. H. Hintze. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ. Res. 78: 58-64, 1996.
38. - excretion in the urine as an indicator of the release of endothelium-derived relaxing factor during elevation of blood pressure. Clin. Sci. (Colch.) 82: 631-634, 1992.
39. Teerlink, J. R., G. A. Gray, M. Clozel, and J.-P. Clozel. Increased vascular responsiveness to norepinephrine in rats with heart failure is endothelium dependent: dissociation of basal and stimulated nitric oxide release. Circulation 89: 393-401, 1994.
40. Veldkamp, P. J., P. K. Carmines, E. W. Inscho, and L. G. Navar. Direct evaluation of the microvascular actions of ANP in juxtamedullary nephrons. Am. J. Physiol. 254 (Renal Fluid Electrolyte Physiol. 23): F440-F444, 1988.
41. Winlaw, D. S., G. A. Smythe, A. M. Keogh, C. G. Schyvens, P. M. Spratt, and P. S. Macdonald. Increased nitric oxide production in heart failure. Lancet 344: 373-374, 1994.